(Q39317792)

11 September 2017

title

EP4 receptor signalling in immature B cells involves cAMP and NF-κB dependent pathways (English)

1 reference

11 September 2017

0 references

Matevz Prijatelj

1

1 reference

11 September 2017

Teja Celhar

series ordinal

2

1 reference

11 September 2017

Martina Gobec

series ordinal

3

1 reference

11 September 2017

Irena Mlinaric-Rascan

series ordinal

4

1 reference

11 September 2017

publication date

22 March 2012

1 reference

Journal of Pharmacy and Pharmacology

11 September 2017

published in

1 reference

11 September 2017

volume

64

1 reference

11 September 2017

issue

8

1 reference

11 September 2017

page(s)

1090-1098

1 reference

Genetic analysis of B cell antigen receptor signaling

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01499.X

A Myc-regulated transcriptional network controls B-cell fate in response to BCR triggering

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01499.X

Cyclooxygenases and prostaglandins: shaping up the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01499.X

Prostaglandins as modulators of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01499.X

Prostaglandin EP4 receptor enhances BCR-induced apoptosis of immature B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01499.X

Prostaglandin E2 regulates B cell proliferation through a candidate tumor suppressor, Ptger4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01499.X

Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01499.X

Prostaglandin E2 increases growth and motility of colorectal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01499.X

Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01499.X

Prostaglandin E receptor type 4-associated protein interacts directly with NF-kappaB1 and attenuates macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01499.X

B cell receptor-mediated nuclear fragmentation proceeds in WEHI 231 cells in the absence of detectable DEVDase and FRase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01499.X

Cyclic nucleotide analogs as probes of signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01499.X

B cell receptor-induced growth arrest and apoptosis in WEHI-231 immature B lymphoma cells involve cyclic AMP and Epac proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01499.X

NF-kappaB inducible genes BCL-X and cyclin E promote immature B-cell proliferation and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01499.X

Prostaglandin E receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01499.X

Prostaglandin E2 inhibits B lymphocyte activation by a cAMP-dependent mechanism: PGE-inducible regulatory proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01499.X

The activity of constitutive nitric oxide synthase is increased by the pathway cAMP/cAMP-activated protein kinase in human platelets. New insights into the antiaggregating effects of cAMP-elevating agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01499.X

Peroxynitrite causes phosphorylation of vasodilator-stimulated phosphoprotein through a PKC dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01499.X

The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01499.X

EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells. Evidence of a BRCA1 and p300 exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01499.X

PI3K signaling controls cell fate at many points in B lymphocyte development and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01499.X

The role of Rel/NF-kappaB transcription factors in B lymphocyte survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01499.X

Regulation and function of NF-kappaB transcription factors in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01499.X

The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01499.X

10.1111/J.2042-7158.2012.01499.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference